Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Currency
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Halozyme Therapeutics (DE:RV7)
FRANKFURT:RV7
Halozyme (RV7) Earnings Date & Reports
0 Followers
Earnings Data
Report Date
Feb 20, 2024TBA Not Confirmed
Period Ending
2023 (Q4)Consensus EPS Forecast
€0.71Last Year’s EPS
€0.39Same Quarter Last Year
Moderate Buy
Based on 9 Analysts Ratings
---
DE:RV7 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
DE:RV7 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 06, 2023 | €32.98 | €32.69 | -0.88% |
| Aug 08, 2023 | €37.87 | €40.59 | +7.18% |
| May 09, 2023 | €27.43 | €29.13 | +6.20% |
| Feb 21, 2023 | €46.43 | €47.89 | +3.14% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Halozyme Therapeutics (DE:RV7) report earnings?
Halozyme Therapeutics (DE:RV7) is schdueled to report earning on Feb 20, 2024, TBA Not Confirmed.
What is Halozyme Therapeutics (DE:RV7) earnings time?
Halozyme Therapeutics (DE:RV7) earnings time is at Feb 20, 2024, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Halozyme Therapeutics stock?
The P/E ratio of Halozyme is N/A.
What is DE:RV7 EPS forecast?
DE:RV7 EPS forecast for the fiscal quarter 2023 (Q4) is €0.71.
---